Market Tracker

11/28 6:05pm ET

Endocyte Inc (NASDAQ:ECYT)

--
Data as of --
-- -- / --
Today’s Change
5.31
Today|||52-Week Range
33.70
--
Year-to-Date

Today’s Trading

Previous close--
Today’s open--
Day’s range-- - --
Volume--
Average volume (3 months)--
Market cap$274.0M
Dividend yield--
Data as of --

Growth & Valuation

Earnings growth (last year)-4.17%
Earnings growth (this year)+112.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.04%
P/E ratio30.9
Price/Sales5.93
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.07-1.39%
AMBIAmbit Biosciences Co...----
AKBAAkebia Therapeutics ...-1.04-7.93%
PPHMPeregrine Pharmaceut...-0.03-1.99%
Data as of 12:59pm ET, 11/28/2014

Financials

Next reporting dateFebruary 23, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$64.9M
Annual profit (last year)-$18.0M
Net profit margin-27.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts